Pediatric T‐cell Acute Lymphoblastic Leukemia with Transient Pure Red Cell Aplasia
Mingying Zhang,Shaoyan Hu,Neetika Ashwani,Jingyuan Li,Wenli Zhao,Hailong He
DOI: https://doi.org/10.1002/pbc.23407
2012-01-01
Abstract:To the Editor: T-cell acute lymphoblastic leukemia (T-ALL) is a lymphoid malignancy, while pure red cell aplasia (PRCA) is a hematological disorder, characterized by isolated failure of erythropoiesis. We herein report a case of childhood transient PRCA followed by T-ALL. A 4-year-old male presented with a 2-month history of progressive pallor, fatigue, and erythrocytopenia. Physical examination revealed significant skin and mucosal pallor. Complete blood counts (CBC) showed erythrocytes of 1.87 × 1012/L, hemoglobin of 5.7 g/dl, mean corpuscular volume of 86 fl/cell, mean corpuscular hemoglobin of 28 pg/cell, platelets of 115 × 109/L, leukocytes of 4.05 × 109/L, and 0.14% reticulocytes. Bone marrow aspiration revealed 1% erythroblasts. Myeloblasts and promyelocytes represented 1% and 2%, respectively. Lymphocytes were 35%, and megakaryocytes were in normal number (Fig. 1A). Cytogenetic analysis showed karyotype was 46,XY. Serum virology showed that the cytomegalovirus, Epstein–Barr virus, and parvovirus B19 were all negative. Ferritin level was within normal limits. CD55 and CD59 detected on flow cytometry were normal. Autoimmune antibody and hemolytic anemia testing were all negative. A CT scan of the chest and abdomen were normal, without enlargement of the antero-posterior mediastinum nor any hepatoslenomagaly. According to clinical symptoms, positive physical sign of severe anemia, typical laboratory evidences of normocytic, normochromic anemia, reticulocytopenia, and a paucity of erythroid precursors in the marrow, the diagnosis of PRCA was made. However, flow cytometric immunophenotyping was not done. A: Bone marrow aspiration revealed erythroid hypoplasia. Normal production of myeloid and lymphoid cells and megakaryocytes but rare erythroblasts (1%). B: Bone marrow aspiration after acute lymphoblastic leukemia transformed. Lymphoblasts were presented up to 41%. (Wright–Giemsa, ×1000.) Methylprednisolone, androgen, and cyclosporin A were administrated. One month later, the patient was re-admitted with fever and cough. Physical examination showed severe pallor, rales, and hepatosplenomegaly. CBC showed erythrocytes of 1.81 × 1012/L, hemoglobin of 5.7 g/dl, platelets of 146 × 109/L, and leukocytes of 76.68 × 109/L. Peripheral blood smear revealed 60% immature cells. Bone marrow aspiration revealed that 41% of cells were leukemic and myeloperoxidase negative (Fig. 1B). Immunophenotyping showed the blasts were CD7(+), cCD3(+), and CD45(+) of 98.1%, 96.9%, and 100%, respectively, while myeloperoxidase were negative. Karyotype analysis showed a normal karyotype (46,XY). The patient was diagnosed with T-ALL. Oral prednisone was administrated for 1 week and blast cells in the peripheral blood were up to 82%. By the end of induction therapy that included vincristine (VCR) (1.5 mg/m2/day, per week × 4), daunorubicin (DNR) (30 mg/m2/day, per week × 4), L-asparaginase (5,000 U/m2/day, qod × 8), and dexamethasone (6 mg/m2/day, 28 days), the marrow leukemic blast cells were 53%. The patient presented with severe hepatosplenomegaly, ascites, peripheral edema, and a respiratory infection. The family requested no further therapy and the patient died of progressive disease. PRCA has been reported in association with lymphoid malignancies including chronic lymphocytic leukemia 1, T-large cell granular lymphocytic leukemia 2, and lymphomas 3. de Alarcon et al. 4 described a single case of erythroid hypoplasia and childhood ALL of undetermined lineage. Imamura et al. 5 reported a case of PRCA with ALL of pre-T-cell origin. The primary resistance of our patient's leukemia to first line ALL therapy is consistent with the poor response to therapy reported by others for malignancies associated with PRCA.